Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 15, 650-656, November 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bostick, W. L.
Right arrow Articles by Hanna, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bostick, W. L.
Right arrow Articles by Hanna, L.

Characteristics of a Virus Isolated from Hodgkin's Disease Lymph Nodes*

Warren L. Bostick and Lavelle Hanna

( Department of Pathology, University of California School of Medicine, San Francisco 22, Calif.)

Hodgkin's disease and control human lymph node tissues have been studied and compared by intracerebral serial inoculations into suckling mice. After five to seven blind passages, a viral agent was detected in three cases of Hodgkin's disease, two of which have been maintained and studied. Although the same mouse strain and technics were used in control material, no agent was encountered in it.

The viruses isolated from the Hodgkin's disease tissues produced a fatal encephalitis, manifest 7–10 days after inoculation. Only intracerebral injections were effective in the initially isolated strain. Intraperitoneal and intramuscular routes were not effective. After seventeen serial intracerebral passages in mice it became adapted to intraperitoneal transfer.

Microscopically, the lesion was a diffuse severe encephalitis demonstrating, for the most part, a round-cell response. The spinal cord was also affected diffusely, so that the clinical symptoms were ataxia, flaccid paralysis, and death. Complete microscopic examination failed to reveal inflammation in muscles, fat, liver, pancreas, lungs, kidneys, etc.

The agent was inactivated at 56° C. in 30 minutes and was resistant to ether. It produced no discernible lesions in chicken eggs or in tissue culture. Complement-fixing antibodies could be produced in immunized rabbits and, with difficulty, in young adult mice. No neutralizing antibodies have been produced in these animals. Human Hodgkin's disease and control sera have not been found to possess complement-fixing antibodies. Commercial human immune globulin possessed neutralizing ability.

A great effort has been made to rule out the possibility that the isolated agents may represent examples of latent mouse or chicken virus. It is felt that the agent is a new type of virus which has truly been isolated from human Hodgkin's disease lymph node tissues. The direct relationship of this virus to Hodgkin's disease must be further clarified and will be the immediate object of further research.

* This investigation has been supported by the Dorothy H. and Lewis Rosenstiel Foundation and was conducted in collaboration with Dr. Karl F. Meyer, George Williams Hooper Foundation, University of California, San Francisco.

Received 3/30/55.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1955 by the American Association for Cancer Research.